← FDA Drug Approvals (Drugs@FDA)

FOSPHENYTOIN SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2023-10-13

Drug application

FDA Application #

ANDA214926

Application type

Abbreviated New Drug Application (Generic)

Brand name

FOSPHENYTOIN SODIUM

Generic name

FOSPHENYTOIN SODIUM

Active ingredients

FOSPHENYTOIN SODIUM

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

GLAND

Manufacturer

Sagent Pharmaceuticals

First approval

2023-10-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown